No Data
Salesforce, IBM Share Losses Contribute To Dow's 100-Point Drop
10 Health Care Stocks With Whale Alerts In Today's Session
Dow's 115-Point Rally Highlighted By Gains In Chevron, Boeing Stocks
Shareholders Will Be Pleased With The Quality of Merck's (NYSE:MRK) Earnings
AI empowers the FDA! Drug approvals hit the 'fast-forward' button, and a large number of pharmaceutical companies may welcome a 'Gold' period.
The USA Food and Drug Administration (FDA) announced an accelerated plan on Thursday to fully implement AI applications across all subsidiary institutions by June 30, aiming to significantly expedite the approval process for new pharmaceuticals.
FDA to Speed up AI Rollout to Accelerate Drug Reviews